[144] Hims & Hers Health, Inc. SEC Filing
Hims & Hers Health, Inc. (HIMS) filed a Form 144 reporting that insider Michael Y. Chi plans to sell up to 13,750 Class A shares through Fidelity Brokerage on or after 07/23/2025. At the stated aggregate market value of $770,000, the sale equals roughly 0.006 % of the company鈥檚 215,453,899 shares outstanding, implying minimal dilution or governance impact.
The shares stem from option exercises dated 02/24/2022, 08/10/2022 and 03/01/2023, all paid in cash on 07/23/2025. Chi has already sold 27,602 shares in the prior three months, generating $1.62 million in gross proceeds at prices recorded on 06/06, 06/10 and 06/17 2025.
Although the volume is modest versus float, continued dispositions may be interpreted by some investors as an insider sentiment signal. No new operational or financial metrics are included in the filing.
Hims & Hers Health, Inc. (HIMS) ha presentato un modulo Form 144 segnalando che l'insider Michael Y. Chi intende vendere fino a 13.750 azioni di Classe A tramite Fidelity Brokerage a partire dal 23/07/2025. Al valore di mercato aggregato dichiarato di 770.000 $, la vendita rappresenta circa lo 0,006% delle 215.453.899 azioni in circolazione della societ脿, implicando un impatto minimo in termini di diluizione o governance.
Le azioni derivano dall'esercizio di opzioni datate 24/02/2022, 10/08/2022 e 01/03/2023, tutte pagate in contanti il 23/07/2025. Chi ha gi脿 venduto 27.602 azioni nei tre mesi precedenti, generando 1,62 milioni di $ di ricavi lordi ai prezzi registrati il 06/06, 10/06 e 17/06/2025.
Nonostante il volume sia modesto rispetto al flottante, ulteriori cessioni potrebbero essere interpretate da alcuni investitori come un segnale sul sentiment interno. Nel modulo non sono inclusi nuovi dati operativi o finanziari.
Hims & Hers Health, Inc. (HIMS) present贸 un Formulario 144 informando que el insider Michael Y. Chi planea vender hasta 13,750 acciones Clase A a trav茅s de Fidelity Brokerage a partir del 23/07/2025. Al valor de mercado agregado declarado de 770,000 $, la venta equivale aproximadamente al 0.006% de las 215,453,899 acciones en circulaci贸n de la compa帽铆a, lo que implica un impacto m铆nimo en diluci贸n o gobernanza.
Las acciones provienen del ejercicio de opciones fechadas el 24/02/2022, 10/08/2022 y 01/03/2023, todas pagadas en efectivo el 23/07/2025. Chi ya ha vendido 27,602 acciones en los tres meses anteriores, generando 1.62 millones de $ en ingresos brutos a precios registrados el 06/06, 10/06 y 17/06/2025.
Aunque el volumen es modesto en comparaci贸n con el flotante, disposiciones continuas podr铆an ser interpretadas por algunos inversores como una se帽al del sentimiento del insider. No se incluyen nuevos datos operativos o financieros en la presentaci贸n.
Hims & Hers Health, Inc. (HIMS)電� 雮措秬鞛� Michael Y. Chi臧赌 2025雲� 7鞗� 23鞚� 鞚错泟 Fidelity Brokerage毳� 韱淀暣 斓滊寑 13,750欤� 韥措灅鞀� A 欤检嫕鞚� 毵る弰頃� 瓿勴殟鞛勳潉 氤搓碃頃橂姅 Form 144毳� 鞝滌稖頄堨姷雼堧嫟. 氇呾嫓霅� 齑� 鞁滌灔 臧赌旃橂姅 770,000雼煬搿�, 鞚措姅 須岇偓鞚� 215,453,899欤� 氚滍枆 欤检嫕鞚� 鞎� 0.006%鞐� 頃措嫻頃橃棳 頋劃鞚措倶 歆�氚瓣惮臁办棎 氙胳箻電� 鞓來枼鞚� 氙鸽頃╇媹雼�.
頃措嫻 欤检嫕鞚� 2022雲� 2鞗� 24鞚�, 2022雲� 8鞗� 10鞚�, 2023雲� 3鞗� 1鞚检棎 頄夓偓霅� 鞓奠厴鞐愳劀 牍勲’霅橃棃鞙茧┌, 氇憪 2025雲� 7鞗� 23鞚� 順勱笀鞙茧 歆�旮夒悩鞐堨姷雼堧嫟. Chi電� 鞚措 歆�雮� 3臧滌洈 霃欖晥 27,602欤�毳� 毵る弰頃橃棳 2025雲� 6鞗� 6鞚�, 6鞗� 10鞚�, 6鞗� 17鞚检棎 旮半霅� 臧赌瓴╈溂搿� 齑� 162毵� 雼煬鞚� 齑濎垬鞚奠潉 鞓牳鞀惦媹雼�.
鞙犿喌 欤检嫕 靾橃棎 牍勴暣 瓯半灅霟夓潃 鞝侅毵�, 歆�靻嶌爜鞚� 毵る弰電� 鞚茧秬 韴瀽鞛愲摛鞐愱矊 雮措秬鞛愳潣 鞁Μ 鞁犿樃搿� 頃挫劃霅� 靾� 鞛堨姷雼堧嫟. 鞚措矆 鞁犼碃靹滌棎電� 靸堧鞖� 鞖挫榿 霕愲姅 鞛 歆�響滉岸� 韽暔霅橃柎 鞛堨 鞎婌姷雼堧嫟.
Hims & Hers Health, Inc. (HIMS) a d茅pos茅 un formulaire 144 indiquant que l'initi茅 Michael Y. Chi pr茅voit de vendre jusqu'脿 13 750 actions de Classe A via Fidelity Brokerage 脿 partir du 23/07/2025. 脌 la valeur marchande agr茅g茅e d茅clar茅e de 770 000 $, la vente repr茅sente environ 0,006 % des 215 453 899 actions en circulation de la soci茅t茅, impliquant un impact minimal sur la dilution ou la gouvernance.
Les actions proviennent d'exercices d'options dat茅s du 24/02/2022, 10/08/2022 et 01/03/2023, toutes r茅gl茅es en esp猫ces le 23/07/2025. Chi a d茅j脿 vendu 27 602 actions au cours des trois derniers mois, g茅n茅rant 1,62 million de $ de produit brut aux prix enregistr茅s les 06/06, 10/06 et 17/06/2025.
Bien que le volume soit modeste par rapport au flottant, des cessions continues pourraient 锚tre interpr茅t茅es par certains investisseurs comme un signal du sentiment des initi茅s. Aucun nouveau indicateur op茅rationnel ou financier n'est inclus dans le d茅p么t.
Hims & Hers Health, Inc. (HIMS) hat ein Formular 144 eingereicht, in dem Insider Michael Y. Chi plant, bis zu 13.750 Class A-Aktien 眉ber Fidelity Brokerage am oder nach dem 23.07.2025 zu verkaufen. Zum angegebenen aggregierten Marktwert von 770.000 $ entspricht der Verkauf etwa 0,006 % der 215.453.899 ausstehenden Aktien des Unternehmens, was auf eine minimale Verw盲sserung oder Governance-Auswirkung hinweist.
Die Aktien stammen aus Optionsaus眉bungen vom 24.02.2022, 10.08.2022 und 01.03.2023, alle bar bezahlt am 23.07.2025. Chi hat bereits 27.602 Aktien in den vorangegangenen drei Monaten verkauft und dabei 1,62 Millionen $ Bruttoerl枚se zu Preisen erzielt, die am 06.06., 10.06. und 17.06.2025 notiert wurden.
Obwohl das Volumen im Vergleich zum Streubesitz gering ist, k枚nnten fortlaufende Verk盲ufe von einigen Investoren als Insider-Sentiment interpretiert werden. Im Formular sind keine neuen operativen oder finanziellen Kennzahlen enthalten.
- Sale volume is only 0.006 % of shares outstanding, implying negligible dilution or control impact.
- Transparent Rule 144 disclosure allows investors to monitor insider activity in real time.
- Continued insider selling (41,352 shares including planned sale) within four months can be perceived as a bearish sentiment signal.
- No accompanying business updates to offset potential negative perception of insider dispositions.
Insights
TL;DR 鈥� Small, routine insider sale; negligible balance-sheet impact, watch sentiment.
The proposed sale of 13,750 shares (~$0.77 M) is immaterial to HIMS鈥檚 215 M share base. Coupled with 27.6 k shares sold since June, the pattern looks like ongoing liquidity from option exercises rather than strategic divestment. No fundamentals change; therefore, the filing is neutral in valuation terms, but repeated selling could weigh on short-term sentiment for momentum traders.
TL;DR 鈥� Governance neutral; disclosure complies, but insider selling trend bears monitoring.
Chi鈥檚 sale is properly disclosed under Rule 144 and represents <0.01 % of shares, posing no control risk. However, incremental insider dispositions鈥攖hree in the last quarter plus this notice鈥攎ay attract scrutiny from investors tracking insider confidence metrics. Absent larger aggregated sales or undisclosed adverse information (affirmatively denied in the form), governance concern is low.
Hims & Hers Health, Inc. (HIMS) ha presentato un modulo Form 144 segnalando che l'insider Michael Y. Chi intende vendere fino a 13.750 azioni di Classe A tramite Fidelity Brokerage a partire dal 23/07/2025. Al valore di mercato aggregato dichiarato di 770.000 $, la vendita rappresenta circa lo 0,006% delle 215.453.899 azioni in circolazione della societ脿, implicando un impatto minimo in termini di diluizione o governance.
Le azioni derivano dall'esercizio di opzioni datate 24/02/2022, 10/08/2022 e 01/03/2023, tutte pagate in contanti il 23/07/2025. Chi ha gi脿 venduto 27.602 azioni nei tre mesi precedenti, generando 1,62 milioni di $ di ricavi lordi ai prezzi registrati il 06/06, 10/06 e 17/06/2025.
Nonostante il volume sia modesto rispetto al flottante, ulteriori cessioni potrebbero essere interpretate da alcuni investitori come un segnale sul sentiment interno. Nel modulo non sono inclusi nuovi dati operativi o finanziari.
Hims & Hers Health, Inc. (HIMS) present贸 un Formulario 144 informando que el insider Michael Y. Chi planea vender hasta 13,750 acciones Clase A a trav茅s de Fidelity Brokerage a partir del 23/07/2025. Al valor de mercado agregado declarado de 770,000 $, la venta equivale aproximadamente al 0.006% de las 215,453,899 acciones en circulaci贸n de la compa帽铆a, lo que implica un impacto m铆nimo en diluci贸n o gobernanza.
Las acciones provienen del ejercicio de opciones fechadas el 24/02/2022, 10/08/2022 y 01/03/2023, todas pagadas en efectivo el 23/07/2025. Chi ya ha vendido 27,602 acciones en los tres meses anteriores, generando 1.62 millones de $ en ingresos brutos a precios registrados el 06/06, 10/06 y 17/06/2025.
Aunque el volumen es modesto en comparaci贸n con el flotante, disposiciones continuas podr铆an ser interpretadas por algunos inversores como una se帽al del sentimiento del insider. No se incluyen nuevos datos operativos o financieros en la presentaci贸n.
Hims & Hers Health, Inc. (HIMS)電� 雮措秬鞛� Michael Y. Chi臧赌 2025雲� 7鞗� 23鞚� 鞚错泟 Fidelity Brokerage毳� 韱淀暣 斓滊寑 13,750欤� 韥措灅鞀� A 欤检嫕鞚� 毵る弰頃� 瓿勴殟鞛勳潉 氤搓碃頃橂姅 Form 144毳� 鞝滌稖頄堨姷雼堧嫟. 氇呾嫓霅� 齑� 鞁滌灔 臧赌旃橂姅 770,000雼煬搿�, 鞚措姅 須岇偓鞚� 215,453,899欤� 氚滍枆 欤检嫕鞚� 鞎� 0.006%鞐� 頃措嫻頃橃棳 頋劃鞚措倶 歆�氚瓣惮臁办棎 氙胳箻電� 鞓來枼鞚� 氙鸽頃╇媹雼�.
頃措嫻 欤检嫕鞚� 2022雲� 2鞗� 24鞚�, 2022雲� 8鞗� 10鞚�, 2023雲� 3鞗� 1鞚检棎 頄夓偓霅� 鞓奠厴鞐愳劀 牍勲’霅橃棃鞙茧┌, 氇憪 2025雲� 7鞗� 23鞚� 順勱笀鞙茧 歆�旮夒悩鞐堨姷雼堧嫟. Chi電� 鞚措 歆�雮� 3臧滌洈 霃欖晥 27,602欤�毳� 毵る弰頃橃棳 2025雲� 6鞗� 6鞚�, 6鞗� 10鞚�, 6鞗� 17鞚检棎 旮半霅� 臧赌瓴╈溂搿� 齑� 162毵� 雼煬鞚� 齑濎垬鞚奠潉 鞓牳鞀惦媹雼�.
鞙犿喌 欤检嫕 靾橃棎 牍勴暣 瓯半灅霟夓潃 鞝侅毵�, 歆�靻嶌爜鞚� 毵る弰電� 鞚茧秬 韴瀽鞛愲摛鞐愱矊 雮措秬鞛愳潣 鞁Μ 鞁犿樃搿� 頃挫劃霅� 靾� 鞛堨姷雼堧嫟. 鞚措矆 鞁犼碃靹滌棎電� 靸堧鞖� 鞖挫榿 霕愲姅 鞛 歆�響滉岸� 韽暔霅橃柎 鞛堨 鞎婌姷雼堧嫟.
Hims & Hers Health, Inc. (HIMS) a d茅pos茅 un formulaire 144 indiquant que l'initi茅 Michael Y. Chi pr茅voit de vendre jusqu'脿 13 750 actions de Classe A via Fidelity Brokerage 脿 partir du 23/07/2025. 脌 la valeur marchande agr茅g茅e d茅clar茅e de 770 000 $, la vente repr茅sente environ 0,006 % des 215 453 899 actions en circulation de la soci茅t茅, impliquant un impact minimal sur la dilution ou la gouvernance.
Les actions proviennent d'exercices d'options dat茅s du 24/02/2022, 10/08/2022 et 01/03/2023, toutes r茅gl茅es en esp猫ces le 23/07/2025. Chi a d茅j脿 vendu 27 602 actions au cours des trois derniers mois, g茅n茅rant 1,62 million de $ de produit brut aux prix enregistr茅s les 06/06, 10/06 et 17/06/2025.
Bien que le volume soit modeste par rapport au flottant, des cessions continues pourraient 锚tre interpr茅t茅es par certains investisseurs comme un signal du sentiment des initi茅s. Aucun nouveau indicateur op茅rationnel ou financier n'est inclus dans le d茅p么t.
Hims & Hers Health, Inc. (HIMS) hat ein Formular 144 eingereicht, in dem Insider Michael Y. Chi plant, bis zu 13.750 Class A-Aktien 眉ber Fidelity Brokerage am oder nach dem 23.07.2025 zu verkaufen. Zum angegebenen aggregierten Marktwert von 770.000 $ entspricht der Verkauf etwa 0,006 % der 215.453.899 ausstehenden Aktien des Unternehmens, was auf eine minimale Verw盲sserung oder Governance-Auswirkung hinweist.
Die Aktien stammen aus Optionsaus眉bungen vom 24.02.2022, 10.08.2022 und 01.03.2023, alle bar bezahlt am 23.07.2025. Chi hat bereits 27.602 Aktien in den vorangegangenen drei Monaten verkauft und dabei 1,62 Millionen $ Bruttoerl枚se zu Preisen erzielt, die am 06.06., 10.06. und 17.06.2025 notiert wurden.
Obwohl das Volumen im Vergleich zum Streubesitz gering ist, k枚nnten fortlaufende Verk盲ufe von einigen Investoren als Insider-Sentiment interpretiert werden. Im Formular sind keine neuen operativen oder finanziellen Kennzahlen enthalten.
FAQ
How many HIMS shares does Michael Y. Chi plan to sell under this Form 144?
What percentage of Hims & Hers Health鈥檚 outstanding shares does the proposed sale represent?
Have there been recent insider sales by the same individual?
When is the earliest date the shares may be sold?
Are these shares newly issued or option-exercised?
Does the filing include any financial performance data for HIMS?
